SK Life Science plots 2020 launch for newly minted seizure med by Eric Sagonowsky Friday, November 22, 2019 With FDA approval for seizure med Xcopri, Korean drugmaker SK Life Science is gearing up for a launch early next year—provided the DEA cooperates.
